BSEInsider Trading / SAST6d ago · 29 Jul 2026, 12:23 pm
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 29, 2026 for Aayush Agrawal, trustee ....
Ajanta Pharma Ltd · 532331
✦ AI SummaryRelated Party
Ajanta Pharma Ltd has made a disclosure under SEBI (SAST) Regulations, 2011, regarding a substantial acquisition of shares by Aayush Agrawal, trustee, on July 29, 2026.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern2/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.